DA-032 15 (Abilify MyCite 15 mg)

Generic Name: aripiprazole

Pill with imprint DA-032 15 is Yellow, Round and has been identified as Abilify mycite 15 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd.

Abilify MyCite is used in the treatment of bipolar disorder; depression; schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Abilify MyCite 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DA-032 15

Abilify mycite

Generic Name:

aripiprazole

Imprint:

DA-032 15

Strength:

15 mg

Color:

Yellow

Shape:

Round

Availability:

Prescription only

Drug Class:

Atypical antipsychotics

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Otsuka Pharmaceutical Co., Ltd

National Drug Code (NDC):

59148-0032

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.